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LETTERS TO THE EDITOR
Some Questions Regarding
Myocardial Bridges Still Require Answers
Among the first groups to investigate such coronary anomalies, Dr.
Bourassa and collaborators in a recent review (1) attempted to
summarize current knowledge on the difficult subject of myocardial
bridges. I would like to discuss some notions that were suggested
by the investigators.
First, the concept of “symptomatic” muscular bridges (which the
review is said to be concerned with) is not defined and indeed is
quite unlikely to be definable, especially while reviewing the
literature. Such observation is fundamental when an investigator
attempts to establish anatomo-clinical correlations in a matter of
coronary anomalies. Indeed, one still cannot identify any consistent
clinical manifestations of muscular bridges (as expected to be
found, for example, in fixed severe coronary obstructions). What
literature reviews can do at their best is to establish correlations in
the specific cases that are being published. It is likely that some 2%
of the general population (possibly 120 million people in the
world) carry an angiographically recognizable muscular bridge, but
only few cases are symptomatic and/or have been published. No
large prospective series has yet been studied, and the problem of
the denominator (the number of people with similar anatomic
features of the few published) is the recurrent limit of clinical
studies of patients with coronary anomalies (2). Ideally, a large
population with anatomically similar anomalies and with similar
functional correlates should be entered into a large multicenter
database, using prospective, agreed-upon protocols that could
study the natural history of such patients (2).
Second, the recent availability of newer, more refined imaging
techniques (such as intravascular ultrasound) and use of functional
testing (Doppler or pressure wires and coronary reserve indexes)
have succeeded in improving the precision of new descriptive
parameters, but they have not yet resulted in proving a necessarily
ischemic implication of muscular bridges. In particular, the finding
of a mildly diminished coronary flow reserve (typically by Doppler
flow velocity measurements) does not explain resting nor severe
angina (that can be expected only with more limited reserve) nor
the probability to predict acute myocardial infarction or sudden
death, the typical clinical correlates in literature reports. Such
events are the real strong indicators for interventions. Doppler
findings of peculiar (typical) flow patterns are possibly diagnostic
of such anomalies, but they are not necessarily predictive per se of
clinical events.
Finally, although the problem of establishing firm, objective
criteria for indicating interventional treatment in muscular bridges
remains substantially unsolved, the decision on which intervention
should be contemplated as an alternative to medical treatment is
not so routine, as stated by the investigators (“these interventions
are not strikingly different from those of patients with single-vessel
coronary disease”). Indeed, both coronary stents and mammary
artery implantation were recognized to have important peculiarities
when implemented in such coronary anomalies. Stents have been
reported to lead to 46% restenosis rate at seven weeks’ angio-
graphic follow-up, in a series of 11 patients (3). Besides intimal
fibrocellular growth and clotting, crushing of a nonelastic metallic
stent is expected in the presence of muscular bridges-related
phasically active collapsing forces (4). Furthermore, mammary
artery implantation has been recognized to frequently undergo
atrophy when used in patients without significant baseline hemo-
dynamic gradients (5).
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REPLY
In his comments on our recent state-of-the-art study (1), Dr.
Angelini implies that our literature review on symptomatic myo-
cardial bridges failed to define the incidence, natural history, and
pathophysiology of this clinical entity. Although we also believe
that the study of the incidence and natural history of myocardial
bridges should be restricted to specific patient populations, namely
those with typical symptoms and objective signs of ischemia, we
agree that the follow-up of patients with any type of bridging has
not been helpful in the past (2,3). We do not share his view that,
overall, myocardial bridges are unlikely to produce ischemia (4).
Typical angina, exercise-induced ST-segment depression, positive
myocardial scintigraphy, and abnormal intracoronary Doppler flow
velocities are recognized manifestations of ischemia. The mecha-
nism of this ischemia has recently been clarified and consists of
significant diastolic coronary diameter reduction, in addition to
phasic systolic compression. We share Dr. Angelini’s concern
about the correct management of patients with symptomatic
bridges. As we have stated, medical therapy must be the first and
principal strategy, and interventions should be limited to patients
with refractory angina despite medical therapy. Then coronary
stenting and cardiac surgery, especially mammary artery implan-
tation, can achieve long-lasting relief of angina. We are not aware
of cases of crushing of a metallic stent in the presence of a muscular
bridge nor was this mentioned in the investigators’ previous report
(4). Finally, it is well known that mammary graft failure can occur
whenever anterograde flow is unimpaired, underscoring the im-
portance of careful patient selection.
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